{"id":"https://openalex.org/G1908482922","display_name":"New Aminoglycosides to Treat Drug-Resistant Bacteria","description":null,"funder_award_id":"R43AI056617","funder":{"id":"https://openalex.org/F4320337355","display_name":"National Institute of Allergy and Infectious Diseases","doi":"https://doi.org/10.13039/100000060"},"funded_outputs":["https://openalex.org/W2026022945","https://openalex.org/W2061128386","https://openalex.org/W2090749703"],"funded_outputs_count":3,"parent_awards":[],"sub_awards":[],"sub_awards_count":0,"amount":null,"currency":"USD","amount_usd":null,"amount_usd_basis":null,"recipients":[],"recipient_countries":[],"recipient_regions":[],"research_scope":{"is_research":true,"basis":"funder_default","tier":1},"funding_type":"research","funder_scheme":"R43","start_date":"2003-08-01","end_date":"2004-02-28","start_year":2003,"end_year":2004,"landing_page_url":"https://reporter.nih.gov/project-details/6689856","doi":null,"provenance":"nih_exporter","lead_investigator":{"given_name":"STEVEN J","family_name":"SUCHECK","orcid":null,"role_start":null,"affiliation":{"name":"OPTIMER PHARMACEUTICALS, INC.","country":"UNITED STATES","ids":null},"author":{"id":"https://openalex.org/A5022800371","display_name":"Steven J. Sucheck","orcid":"https://orcid.org/0000-0003-0082-3827"},"institutions":null},"co_lead_investigator":null,"investigators":null,"works_api_url":"https://api.openalex.org/works?filter=awards.id:G1908482922","primary_topic":{"id":"https://openalex.org/T10147","display_name":"Antibiotic Resistance in Bacteria","score":0.8374,"subfield":{"id":"https://openalex.org/subfields/2726","display_name":"Microbiology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10147","display_name":"Antibiotic Resistance in Bacteria","score":0.8374,"subfield":{"id":"https://openalex.org/subfields/2726","display_name":"Microbiology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11036","display_name":"Antibiotics Pharmacokinetics and Efficacy","score":0.0726,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10195","display_name":"Antimicrobial Resistance in Staphylococcus","score":0.0223,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/aminoglycosides","display_name":"aminoglycosides","score":0.991},{"id":"https://openalex.org/keywords/drug-resistant-bacteria","display_name":"drug-resistant bacteria","score":0.821},{"id":"https://openalex.org/keywords/antibiotic-resistance","display_name":"antibiotic resistance","score":0.736},{"id":"https://openalex.org/keywords/new-antibiotics","display_name":"novel antibiotics","score":0.496},{"id":"https://openalex.org/keywords/antibacterial-agents","display_name":"antibacterial agents","score":0.783}],"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9391}],"institution_awarded":[],"updated_date":"2026-11-13T03:01:57.000Z","created_date":"2026-10-09T19:56:01.000Z"}
